Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
NKTR
REPL
Add up to 3 more stocks
NKTR
Nektar Therapeutics
-5.47%
$39.91-2.31Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.14B
52W Range
$33.40 - $109.00
REPL
Replimune Group, Inc.
+0.76%
$13.25+0.10Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.11B
52W Range
$1.50 - $16.33
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.27 | 10.54 |
| P/S Ratio | 20.97 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 99.4% | 0.0% |
| Operating Margin | -240.4% | 0.0% |
| Net Margin | -287.8% | 0.0% |
| ROE | -17.4% | -281.1% |
| ROA | -14.3% | -117.7% |
| ROIC | -12.5% | -139.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 10.42 | 5.23 |
| Quick Ratio | 10.42 | 5.23 |
| Debt/Equity | 0.15 | 1.06 |
| Interest Coverage | -4.99 | -36.11 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.